Detailed answers about MERSEYSIDE AUTISM AND SPEECH THERAPY LIMITED, including incorporation, status, business activity, and accounts information.
When was MERSEYSIDE AUTISM AND SPEECH THERAPY LIMITED founded?
MERSEYSIDE AUTISM AND SPEECH THERAPY LIMITED was officially incorporated on 1 April 2016 and is registered under company number 10096776. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is MERSEYSIDE AUTISM AND SPEECH THERAPY LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of MERSEYSIDE AUTISM AND SPEECH THERAPY LIMITED?
MERSEYSIDE AUTISM AND SPEECH THERAPY LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does MERSEYSIDE AUTISM AND SPEECH THERAPY LIMITED do?
MERSEYSIDE AUTISM AND SPEECH THERAPY LIMITED operates in the following sector: 86900 - Other human health activities. This provides insight into the company's primary business activity and industry focus.
What is MERSEYSIDE AUTISM AND SPEECH THERAPY LIMITED's registered address?
The registered office address of MERSEYSIDE AUTISM AND SPEECH THERAPY LIMITED is C/O ELAINE DEVEREUX, MATTHEW SUTTON AND CO LTD, PENNY LANE, LIVERPOOL, UNITED KINGDOM, L18 1DG. This is the official address filed with Companies House for legal and statutory correspondence.
Is MERSEYSIDE AUTISM AND SPEECH THERAPY LIMITED financially stable?
The most recent accounts for MERSEYSIDE AUTISM AND SPEECH THERAPY LIMITED were made up to 30 April 2025, filed as MICRO ENTITY. Next accounts are due by 31 January 2027.